We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+13.31%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$327M
AUM Growth
-$6.98M
Cap. Flow
-$27.2M
Cap. Flow %
-8.32%
Top 10 Hldgs %
35.72%
Holding
92
New
32
Increased
20
Reduced
19
Closed
20

Top Buys

Rank Stock Value
1
RVTY icon
Revvity
RVTY
+$9.19M
2
SNY icon
Sanofi
SNY
+$6.44M
3
ABT icon
Abbott
ABT
+$6.09M
4
CNC icon
Centene
CNC
+$5.9M
5
EHTH icon
eHealth
EHTH
+$5.67M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$13.7M
2
LHCG
LHC Group LLC
LHCG
+$9.87M
3
BMY icon
Bristol-Myers Squibb
BMY
+$9.03M
4
DHR icon
Danaher
DHR
+$7.96M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$7.65M

Sector Composition

Rank Sector Weight
1 Healthcare 85.4%
2 Energy 4.88%
3 Financials 1.69%
4 Consumer Discretionary 0.59%
5 Technology 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
26
Cytokinetics
CYTK
$10.6B
$4.33M 1.32%
200,000
-140,000
-41% -$3.27M
AGIO icon
27
Agios Pharmaceuticals
AGIO
$1.95B
$4.2M 1.28%
120,000
-30,000
-20% -$1.31M
ONC
28
BeOne Medicines Ltd
ONC
$40.6B
$4.15M 1.27%
14,500
+4,500
+45% +$1.06M
HALO icon
29
Halozyme
HALO
$11.6B
$4.07M 1.25%
155,000
+20,000
+15% +$557K
RETA
30
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3.9M 1.19%
+40,000
New +$5M
HOLX
31
DELISTED
Hologic
HOLX
$3.66M 1.12%
+55,000
New +$3.48M
ALNY icon
32
Alnylam Pharmaceuticals
ALNY
$29.6B
$3.64M 1.11%
+25,000
New +$3.55M
MRNA icon
33
PUT
Moderna
MRNA
$24.2B
$3.54M 1.08%
50,000
– –
FATE icon
34
Fate Therapeutics
FATE
$319M
$3.4M 1.04%
85,000
+15,000
+21% +$524K
GH icon
35
Guardant Health
GH
$22.2B
$3.35M 1.03%
+30,000
New +$2.74M
GMED icon
36
Globus Medical
GMED
$11.4B
$3.22M 0.98%
+65,000
New +$3.35M
BAX icon
37
Baxter International
BAX
$14.3B
$3.22M 0.98%
40,000
-10,000
-20% -$841K
UHS icon
38
Universal Health Services
UHS
$9.94B
$3.21M 0.98%
30,000
-35,000
-54% -$3.74M
BMY icon
39
Bristol-Myers Squibb
BMY
$130B
$3.02M 0.92%
50,000
-150,000
-75% -$9.03M
CTLT
40
DELISTED
CATALENT, INC.
CTLT
$3M 0.92%
35,000
-65,000
-65% -$5.5M
PNTG icon
41
Pennant Group
PNTG
$1.33B
$2.89M 0.88%
+75,000
New +$2.3M
IRTC icon
42
iRhythm Holdings
IRTC
$4.02B
$2.86M 0.87%
+12,000
New +$2.12M
MOH icon
43
Molina Healthcare
MOH
$10.2B
$2.75M 0.84%
15,000
-25,000
-63% -$4.55M
BHC icon
44
Bausch Health
BHC
$2.33B
$2.72M 0.83%
+175,000
New +$3.01M
APLS
45
DELISTED
Apellis Pharmaceuticals
APLS
$2.71M 0.83%
+90,000
New +$2.69M
AKRO
46
DELISTED
Akero Therapeutics
AKRO
$2.62M 0.8%
+85,000
New +$2.97M
ITCI
47
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.57M 0.78%
+100,000
New +$2.28M
KPTI icon
48
Karyopharm Therapeutics
KPTI
$47.6M
$2.56M 0.78%
11,667
+6,667
+133% +$1.63M
GOSS icon
49
Gossamer Bio
GOSS
$88.9M
$2.48M 0.76%
200,000
-70,000
-26% -$928K
DXCM icon
50
DexCom
DXCM
$33.8B
$2.47M 0.76%
24,000
-36,000
-60% -$3.76M
1
2
3 4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Integral Health Asset Management held 92 positions worth $327M, down 2.1% from $334M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Integral Health Asset Management withdrew a net $27.2M in Q3 2020, closing 20 positions and reducing 19 holdings. Its most notable exit was Quest Diagnostics, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 87% a quarter earlier, followed by Energy and Financials.

Against the trend, Integral Health Asset Management opened a new position in Sanofi worth $6.27M.

  • Integral Health Asset Management's largest Q3 2020 buy was Sanofi: 125,000 shares worth $6.27M.
  • Integral Health Asset Management added most to Revvity in Q3 2020, an estimated $9.19M increase.
  • Integral Health Asset Management's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $9.87M.
  • Integral Health Asset Management fully exited Quest Diagnostics in Q3 2020, selling an estimated $13.7M.
  • Integral Health Asset Management's ten largest holdings make up 36% of its $327M portfolio in Q3 2020.
  • Integral Health Asset Management opened 32 new positions and closed 20 in Q3 2020.
  • Integral Health Asset Management's portfolio value fell 2.1% quarter-over-quarter to $327M.

Based on Integral Health Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.